from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1161/narG

LFCtreatmentdescriptionclass of inhibitor

0.145

Amikacinug/mL Amikacintranslation

0.160

Cap5-10ug/mL Capreomycintranslation

0.145

Rox10-50 ug/mL Roxithromycintranslation

0.415

SM2-5 ug/mL Streptomycintranslation

-0.684

Tet5-10 ug/mL Tetracyclinetranslation

-0.474

Rif0.2-5ug/mL Rifampicintranscription

-0.451

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.972

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.199

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.381

CPZ10-50 ug/mL Chlorpromazinerespiration

0.051

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.010

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.994

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.049

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.672

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.019

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.192

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.539

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.692

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.250

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.615

KCN5-20 ug/mL Potassium cyaniderespiration

-0.349

NaN30.2-2 mM Sodium aziderespiration

-0.461

Nigericin50 uM Nigericinrespiration

-0.751

TRC10-150 ug/mL Triclosanrespiration

-1.174

TRZ10-25 ug/mL Thioridazinerespiration

2.533

Valinomycin0.5-10 uM Valinomycinrespiration

0.458

ZnSO42 mM ZnSO4respiration

-0.324

menadione6-10 ug/mL Menadionerespiration

-0.286

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.665

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.011

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.474

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.271

NRP_1Non-replicating persistence stage 1dosRassociated

-0.180

Amp0.2mg/mL AmpicillincellWall

-0.492

Cephalexin20-100 ug/mL CephalexincellWall

-0.423

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.584

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.306

EMB10-20 ug/mL EthambutolcellWall

-0.063

Eta12-40 ug/mL EthionamidecellWall

-0.204

INH0.2-0.4 ug/mL IsoniazidcellWall

0.070

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.183

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.671

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.488

BZA0.12 mg/mL BenzamidearomaticAmides

-0.477

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.247

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.374

H2O24 mM hydrogen peroxideDNAdamaging

-0.110

Levo10 ug/mL LevofloxacinDNAdamaging

-0.670

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.186

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.387

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.344

UVUV-irradiationDNAdamaging

-0.650

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.428

Antimycin12.5-50 ug/mL Antimycin A?

-0.704

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.716

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.714

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.196

PA8240.2-2 ug/mL PA-824?

1.482

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.103

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.248

Verapamil50 uM Verapamil?

-0.433

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.055

methoxatin10-20 ug/mL Methoxatin?